Clinical Trial Update: A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates the safety and immunogenicity of a third-generation hepatitis B vaccine across Phase 1 and Phase 2, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Third Generation Hepatitis B Vaccine

Snippet

Sponsor: CHA Vaccine Institute Co., Ltd. | Conditions: Healthy | Phase 1, Phase 2 | Status: COMPLETED